Trial Profile
A trial to study adherence to therapy and safety of denosumab in women with severe osteoporosis followed in a vertebral fracture outpatient unit
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Adverse reactions; Therapeutic Use
- 18 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases